Literature DB >> 22595352

A single institution experience of the incidence of extracranial metastasis in glioma.

Sekhar Amitendu1, Siu Kei David Mak, Ji Min Ling, Wai Hoe Ng.   

Abstract

Glioblastoma multiforme (GBM) is the most common and aggressive subtype of all gliomas. The prognosis is poor but despite the aggressiveness of the tumour, extracranial metastasis of glioma is rare. Most documented cases of extracranial metastases of GBM involve leptomeningeal spread to the spine. In this clinical study we aim to review the incidence and location of extracranial metastasis of glioma from the Brain Tumor Database of the National Neuroscience Institute of Singapore, between September 2004 to October 2009. Four of 148 patients (2.7%) were identified, one of whom had pleomorphic xanthoastrocytoma (PXA) with scalp and spinal metastasis, suggestive of haematogenous rather than cerebrospinal fluid spread that has been described elsewhere. To our knowledge, there has been no published report of PXA with scalp metastasis or vertebral metastasis.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22595352     DOI: 10.1016/j.jocn.2011.08.040

Source DB:  PubMed          Journal:  J Clin Neurosci        ISSN: 0967-5868            Impact factor:   1.961


  13 in total

Review 1.  Circulating glioma biomarkers.

Authors:  Johan M Kros; Dana M Mustafa; Lennard J M Dekker; Peter A E Sillevis Smitt; Theo M Luider; Ping-Pin Zheng
Journal:  Neuro Oncol       Date:  2014-09-24       Impact factor: 12.300

Review 2.  Leptomeningeal Spread in Glioblastoma: Diagnostic and Therapeutic Challenges.

Authors:  Cristina Birzu; Suzanne Tran; Franck Bielle; Mehdi Touat; Karima Mokhtari; Nadia Younan; Dimitri Psimaras; Khe Hoang-Xuan; Marc Sanson; Jean-Yves Delattre; Ahmed Idbaih
Journal:  Oncologist       Date:  2020-08-31

3.  Leptomeningeal disease in glioblastoma: endgame or opportunity?

Authors:  Sarfraz Akmal; Elizabeth E Ginalis; Nitesh V Patel; Robert Aiken; Alis J Dicpinigaitis; Simon J Hanft
Journal:  J Neurooncol       Date:  2021-10-08       Impact factor: 4.130

4.  Is surgical spinal decompression for supratentorial GBM symptomatic drop down metastasis warranted? A case report and review of literature.

Authors:  Muhammad Babar Khan; Muhammad Riaz; Muhammad Ehsan Bari
Journal:  Surg Neurol Int       Date:  2014-03-27

Review 5.  Imaging guidelines and findings of extracranial glioblastoma.

Authors:  Daniel Thomas Ginat; Pamela W Schaefer
Journal:  J Neurooncol       Date:  2014-02-21       Impact factor: 4.130

6.  Glioblastoma metastasis to parotid gland and neck lymph nodes: fine-needle aspiration cytology with histopathologic correlation.

Authors:  Alfredo E Romero-Rojas; Julio A Diaz-Perez; Deirdre Amaro; Alfonso Lozano-Castillo; Sandra I Chinchilla-Olaya
Journal:  Head Neck Pathol       Date:  2013-05-01

Review 7.  Widely metastatic IDH1-mutant glioblastoma with oligodendroglial features and atypical molecular findings: a case report and review of current challenges in molecular diagnostics.

Authors:  Carlos G Romo; Doreen N Palsgrove; Ananyaa Sivakumar; Christen R Elledge; Lawrence R Kleinberg; Kaisorn L Chaichana; Christopher D Gocke; Fausto J Rodriguez; Matthias Holdhoff
Journal:  Diagn Pathol       Date:  2019-02-09       Impact factor: 2.644

Review 8.  Cytology of Extraneural Metastases of Nonhematolymphoid Primary Central Nervous System Tumors: Six Cases with Histopathological Correlation and Literature Update.

Authors:  Joerg Schwock; Lorna Mirham; Zeina Ghorab
Journal:  Acta Cytol       Date:  2021-07-26       Impact factor: 2.319

9.  Surgical Ventricular Entry is a Key Risk Factor for Leptomeningeal Metastasis of High Grade Gliomas.

Authors:  Roland Roelz; Peter Reinacher; Ramazan Jabbarli; Rainer Kraeutle; Beate Hippchen; Karl Egger; Astrid Weyerbrock; Marcia Machein
Journal:  Sci Rep       Date:  2015-12-04       Impact factor: 4.379

Review 10.  Extracranial metastases of high-grade glioma: the clinical characteristics and mechanism.

Authors:  Qian Sun; Rui Xu; Hongbo Xu; Gengming Wang; Xueming Shen; Hao Jiang
Journal:  World J Surg Oncol       Date:  2017-10-06       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.